Hold scientists accountable
By Richard Hayes,
The Baltimore Sun
| 01. 17. 2006
So now it's confirmed that South Korean stem cell king Hwang Woo Suk had been lying all along - not just about the illicit manner in which the women's eggs used in his experiments were obtained, but about his major claim to have successfully created clonal human embryos in the first place. He lied to the news media, the public, his government and patients hoping for cures.
I heard Mr. Hwang speak just over a year ago at a forum at the United Nations. He was lauded by the scientists present as the Galileo of stem cell research. When a reporter asked about rumors that the eggs used in his experiments had been obtained under questionable circumstances, he denied it. None of the other scientists present voiced the least concern.
If we are to learn the most important lessons from this sorry episode, we need to be aware of the broader context.
Mr. Hwang is not the first scientist to have lied or engaged in ethically questionable behavior concerning their experiments with human genes, stem cells or embryos. The new...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...